{"transactions":[{"id":693439,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-06","kind":"exercise","planned":true,"acquired":false,"shares":14292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":60423,"derivative":{"exercise_price":17.84,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":14292},"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":693438,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-05","kind":"exercise","planned":true,"acquired":false,"shares":5849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":74715,"derivative":{"exercise_price":17.84,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":5849},"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":693437,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":9292,"price":29.3375,"value":272604.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 19, 2025."}],"balance_after":67828,"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":693436,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":29,"value":145000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 19, 2025."}],"balance_after":77120,"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":693435,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-06","kind":"exercise","planned":true,"acquired":true,"shares":14292,"price":17.84,"value":254969.28,"ownership":{"direct":true},"balance_after":82120,"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":693434,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-05","kind":"sale","planned":true,"acquired":false,"shares":5849,"price":29.0029,"value":169637.9621,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":67828,"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":693433,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-07T22:00:09.000Z","date":"2026-08-05","kind":"exercise","planned":true,"acquired":true,"shares":5849,"price":17.84,"value":104346.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,683 shares of the Issuer's common stock acquired by the reporting person on May 15, 2026 pursuant to an employee stock purchase plan."}],"balance_after":73677,"source":{"system":"sec-edgar","filing":"0001899977-26-000008","document":"form4-08072026_060801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000008/form4-08072026_060801.xml","form_type":"4"}},{"id":792569,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-05-05T22:00:18.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":6815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":6815,"derivative":{"underlying":"Common Stock","underlying_shares":6815},"source":{"system":"sec-edgar","filing":"0001899977-26-000007","document":"form4-05052026_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000007/form4-05052026_060501.xml","form_type":"4"}},{"id":792568,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-05T22:00:18.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":3506,"price":21.79,"value":76395.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.79 to $21.7932, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":66145,"source":{"system":"sec-edgar","filing":"0001899977-26-000007","document":"form4-05052026_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000007/form4-05052026_060501.xml","form_type":"4"}},{"id":792567,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-05T22:00:18.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":6815,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":69651,"source":{"system":"sec-edgar","filing":"0001899977-26-000007","document":"form4-05052026_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000007/form4-05052026_060501.xml","form_type":"4"}},{"id":813768,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-04-07T23:57:16.000Z","date":"2026-04-05","kind":"exercise","planned":false,"acquired":false,"shares":5276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5276},"source":{"system":"sec-edgar","filing":"0001899977-26-000005","document":"form4-04072026_110411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000005/form4-04072026_110411.xml","form_type":"4"}},{"id":813767,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-07T23:57:16.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":2709,"price":22.2,"value":60139.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":62836,"source":{"system":"sec-edgar","filing":"0001899977-26-000005","document":"form4-04072026_110411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000005/form4-04072026_110411.xml","form_type":"4"}},{"id":813766,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-07T23:57:16.000Z","date":"2026-04-05","kind":"exercise","planned":false,"acquired":true,"shares":5276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":65545,"source":{"system":"sec-edgar","filing":"0001899977-26-000005","document":"form4-04072026_110411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000005/form4-04072026_110411.xml","form_type":"4"}},{"id":827628,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-25","kind":"exercise","planned":false,"acquired":false,"shares":6178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":12358,"derivative":{"underlying":"Common Stock","underlying_shares":6178},"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":827627,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":8138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":24414,"derivative":{"underlying":"Common Stock","underlying_shares":8138},"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":827626,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":37,"price":21.7174,"value":803.5438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":60269,"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":827625,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":3171,"price":21.65,"value":68652.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":60306,"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":827624,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-25","kind":"exercise","planned":false,"acquired":true,"shares":6178,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":63477,"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":827623,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":4177,"price":21.47,"value":89680.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":57299,"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":827622,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-27T00:00:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":8138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":61476,"source":{"system":"sec-edgar","filing":"0001899977-26-000003","document":"form4-03262026_080301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000003/form4-03262026_080301.xml","form_type":"4"}},{"id":851808,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T22:00:15.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":26382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning March 6, 2027."}],"balance_after":26382,"derivative":{"underlying":"Common Stock","underlying_shares":26382},"source":{"system":"sec-edgar","filing":"0001899977-26-000002","document":"form4-03102026_060310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000002/form4-03102026_060310.xml","form_type":"4"}},{"id":851807,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-10T22:00:15.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":90691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":90691,"derivative":{"exercise_price":22.16,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":90691},"source":{"system":"sec-edgar","filing":"0001899977-26-000002","document":"form4-03102026_060310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997726000002/form4-03102026_060310.xml","form_type":"4"}},{"id":994406,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-11-19T23:00:07.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":false,"shares":9913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9913},"source":{"system":"sec-edgar","filing":"0001899977-25-000006","document":"form4-11192025_061103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000006/form4-11192025_061103.xml","form_type":"4"}},{"id":994405,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-11-19T23:00:07.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":false,"shares":9913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9913},"source":{"system":"sec-edgar","filing":"0001899977-25-000006","document":"form4-11192025_061103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000006/form4-11192025_061103.xml","form_type":"4"}},{"id":994404,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:07.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":10262,"price":23.6907,"value":243113.9634,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.69 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":53338,"source":{"system":"sec-edgar","filing":"0001899977-25-000006","document":"form4-11192025_061103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000006/form4-11192025_061103.xml","form_type":"4"}},{"id":994403,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:07.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":9913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":63600,"source":{"system":"sec-edgar","filing":"0001899977-25-000006","document":"form4-11192025_061103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000006/form4-11192025_061103.xml","form_type":"4"}},{"id":994402,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:07.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":9913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 327 shares of the Issuer's common stock acquired by the reporting person on November 14, 2025 pursuant to an employee stock purchase plan."}],"balance_after":53687,"source":{"system":"sec-edgar","filing":"0001899977-25-000006","document":"form4-11192025_061103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000006/form4-11192025_061103.xml","form_type":"4"}},{"id":1039729,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-16T22:00:19.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":3498,"price":23.65,"value":82727.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":43447,"source":{"system":"sec-edgar","filing":"0001899977-25-000004","document":"form4-09162025_100915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000004/form4-09162025_100915.xml","form_type":"4"}},{"id":1039728,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-16T22:00:19.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":6815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on May 1, 2023 at incremental 25% of target. Together with the vesting on August 16, 2024, the performance stock units have vested at 75% of target."}],"balance_after":46945,"source":{"system":"sec-edgar","filing":"0001899977-25-000004","document":"form4-09162025_100915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000189997725000004/form4-09162025_100915.xml","form_type":"4"}},{"id":1062788,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T22:00:07.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":25.1829,"value":554023.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":40130,"source":{"system":"sec-edgar","filing":"0001415889-25-022359","document":"form4-08192025_060803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925022359/form4-08192025_060803.xml","form_type":"4"}},{"id":1143609,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-20T00:50:43.000Z","date":"2025-05-16","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":25,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,357 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan."}],"balance_after":62130,"source":{"system":"sec-edgar","filing":"0001415889-25-013741","document":"form4-05202025_120539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925013741/form4-05202025_120539.xml","form_type":"4"}},{"id":1161640,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-05-02T23:59:08.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":6815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":13630,"derivative":{"underlying":"Common Stock","underlying_shares":6815},"source":{"system":"sec-edgar","filing":"0001415889-25-011872","document":"form4-05022025_110505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925011872/form4-05022025_110505.xml","form_type":"4"}},{"id":1161639,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-02T23:59:08.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":3498,"price":14.6,"value":51070.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":62773,"source":{"system":"sec-edgar","filing":"0001415889-25-011872","document":"form4-05022025_110505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925011872/form4-05022025_110505.xml","form_type":"4"}},{"id":1161638,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-02T23:59:08.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":6815,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":66271,"source":{"system":"sec-edgar","filing":"0001415889-25-011872","document":"form4-05022025_110505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925011872/form4-05022025_110505.xml","form_type":"4"}},{"id":1175971,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-08T23:40:13.000Z","date":"2025-04-05","kind":"exercise","planned":false,"acquired":false,"shares":5275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":5276,"derivative":{"underlying":"Common Stock","underlying_shares":5275},"source":{"system":"sec-edgar","filing":"0001415889-25-010424","document":"form4-04082025_110409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925010424/form4-04082025_110409.xml","form_type":"4"}},{"id":1175970,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-08T23:40:13.000Z","date":"2025-04-08","kind":"sale","planned":false,"acquired":false,"shares":2708,"price":14.82,"value":40132.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":59456,"source":{"system":"sec-edgar","filing":"0001415889-25-010424","document":"form4-04082025_110409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925010424/form4-04082025_110409.xml","form_type":"4"}},{"id":1175969,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-08T23:40:13.000Z","date":"2025-04-05","kind":"exercise","planned":false,"acquired":true,"shares":5275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":62164,"source":{"system":"sec-edgar","filing":"0001415889-25-010424","document":"form4-04082025_110409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925010424/form4-04082025_110409.xml","form_type":"4"}},{"id":1191453,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-03-27T00:06:10.000Z","date":"2025-03-25","kind":"exercise","planned":false,"acquired":false,"shares":6178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":18536,"derivative":{"underlying":"Common Stock","underlying_shares":6178},"source":{"system":"sec-edgar","filing":"0001415889-25-009074","document":"form4-03272025_120306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009074/form4-03272025_120306.xml","form_type":"4"}},{"id":1191452,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-03-27T00:06:10.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":32552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning March 24, 2026."}],"balance_after":32552,"derivative":{"underlying":"Common Stock","underlying_shares":32552},"source":{"system":"sec-edgar","filing":"0001415889-25-009074","document":"form4-03272025_120306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009074/form4-03272025_120306.xml","form_type":"4"}},{"id":1191451,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-27T00:06:10.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":110761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":110761,"derivative":{"exercise_price":17.23,"expiration_date":"2035-03-23","underlying":"Common Stock","underlying_shares":110761},"source":{"system":"sec-edgar","filing":"0001415889-25-009074","document":"form4-03272025_120306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009074/form4-03272025_120306.xml","form_type":"4"}},{"id":1191450,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-27T00:06:10.000Z","date":"2025-03-26","kind":"sale","planned":false,"acquired":false,"shares":3171,"price":17.05,"value":54065.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":56889,"source":{"system":"sec-edgar","filing":"0001415889-25-009074","document":"form4-03272025_120306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009074/form4-03272025_120306.xml","form_type":"4"}},{"id":1191449,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-27T00:06:10.000Z","date":"2025-03-25","kind":"exercise","planned":false,"acquired":true,"shares":6178,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":60060,"source":{"system":"sec-edgar","filing":"0001415889-25-009074","document":"form4-03272025_120306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925009074/form4-03272025_120306.xml","form_type":"4"}},{"id":1247360,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-02-25T23:46:58.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":false,"shares":1353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1353},"source":{"system":"sec-edgar","filing":"0001415889-25-005574","document":"form4-02252025_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925005574/form4-02252025_110254.xml","form_type":"4"}},{"id":1247359,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:46:58.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":773,"price":19.96,"value":15429.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":53882,"source":{"system":"sec-edgar","filing":"0001415889-25-005574","document":"form4-02252025_110254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925005574/form4-02252025_110254.xml","form_type":"4"}},{"id":1247358,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-02-25T23:46:58.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":true,"shares":1353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":54655,"source":{"system":"sec-edgar","filing":"0001415889-25-005574","document":"form4-02252025_110254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925005574/form4-02252025_110254.xml","form_type":"4"}},{"id":1359988,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-11-20T01:40:08.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":false,"shares":9913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":9913,"derivative":{"underlying":"Common Stock","underlying_shares":9913},"source":{"system":"sec-edgar","filing":"0001415889-24-027292","document":"form4-11202024_011103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027292/form4-11202024_011103.xml","form_type":"4"}},{"id":1359987,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-11-20T01:40:08.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":false,"shares":9913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":9913,"derivative":{"underlying":"Common Stock","underlying_shares":9913},"source":{"system":"sec-edgar","filing":"0001415889-24-027292","document":"form4-11202024_011103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027292/form4-11202024_011103.xml","form_type":"4"}},{"id":1359986,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T01:40:08.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":10259,"price":16.81,"value":172453.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.768 to $16.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":53302,"source":{"system":"sec-edgar","filing":"0001415889-24-027292","document":"form4-11202024_011103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027292/form4-11202024_011103.xml","form_type":"4"}},{"id":1359985,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T01:40:08.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":true,"shares":9913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":63561,"source":{"system":"sec-edgar","filing":"0001415889-24-027292","document":"form4-11202024_011103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027292/form4-11202024_011103.xml","form_type":"4"}},{"id":1359984,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T01:40:08.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":true,"shares":9913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":53648,"source":{"system":"sec-edgar","filing":"0001415889-24-027292","document":"form4-11202024_011103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027292/form4-11202024_011103.xml","form_type":"4"}},{"id":1428121,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-20T22:46:23.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":9733,"price":15.28,"value":148720.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $15.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":43735,"source":{"system":"sec-edgar","filing":"0001415889-24-021731","document":"form4-08202024_100820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021731/form4-08202024_100820.xml","form_type":"4"}},{"id":1428120,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-20T22:46:23.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":13629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on May 1, 2023 at 50% of target."}],"balance_after":53468,"source":{"system":"sec-edgar","filing":"0001415889-24-021731","document":"form4-08202024_100820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021731/form4-08202024_100820.xml","form_type":"4"}},{"id":1428119,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-20T22:46:23.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at incremental 25% of target. Together with the vesting on March 25, 2024, the performance stock units have vested at 75% of target."}],"balance_after":39839,"source":{"system":"sec-edgar","filing":"0001415889-24-021731","document":"form4-08202024_100820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021731/form4-08202024_100820.xml","form_type":"4"}},{"id":1483952,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-06-11T22:00:05.000Z","date":"2024-06-08","kind":"exercise","planned":false,"acquired":false,"shares":1893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1893},"source":{"system":"sec-edgar","filing":"0001415889-24-016416","document":"form4-06112024_060601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924016416/form4-06112024_060601.xml","form_type":"4"}},{"id":1483951,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-11T22:00:05.000Z","date":"2024-06-10","kind":"sale","planned":false,"acquired":false,"shares":975,"price":14.79,"value":14420.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.675 to $14.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":34564,"source":{"system":"sec-edgar","filing":"0001415889-24-016416","document":"form4-06112024_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924016416/form4-06112024_060601.xml","form_type":"4"}},{"id":1483950,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-11T22:00:05.000Z","date":"2024-06-08","kind":"exercise","planned":false,"acquired":true,"shares":1893,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,593 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 15, 2024."}],"balance_after":35539,"source":{"system":"sec-edgar","filing":"0001415889-24-016416","document":"form4-06112024_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924016416/form4-06112024_060601.xml","form_type":"4"}},{"id":1529067,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:00:51.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":6814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":20445,"derivative":{"underlying":"Common Stock","underlying_shares":6814},"source":{"system":"sec-edgar","filing":"0001415889-24-012237","document":"form4-05032024_060510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012237/form4-05032024_060510.xml","form_type":"4"}},{"id":1529066,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:51.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":3503,"price":16.94,"value":59340.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":32053,"source":{"system":"sec-edgar","filing":"0001415889-24-012237","document":"form4-05032024_060510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012237/form4-05032024_060510.xml","form_type":"4"}},{"id":1529065,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:51.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":6814,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":35556,"source":{"system":"sec-edgar","filing":"0001415889-24-012237","document":"form4-05032024_060510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012237/form4-05032024_060510.xml","form_type":"4"}},{"id":1544761,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-04-09T22:00:06.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":false,"shares":5275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":10551,"derivative":{"underlying":"Common Stock","underlying_shares":5275},"source":{"system":"sec-edgar","filing":"0001415889-24-010601","document":"form4-04092024_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010601/form4-04092024_060401.xml","form_type":"4"}},{"id":1544760,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:06.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":2716,"price":17.87,"value":48534.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.7338 to $17.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":28742,"source":{"system":"sec-edgar","filing":"0001415889-24-010601","document":"form4-04092024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010601/form4-04092024_060401.xml","form_type":"4"}},{"id":1544759,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:06.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":5275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":31458,"source":{"system":"sec-edgar","filing":"0001415889-24-010601","document":"form4-04092024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010601/form4-04092024_060401.xml","form_type":"4"}},{"id":1559833,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-03-27T23:57:03.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":24714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":24714,"derivative":{"underlying":"Common Stock","underlying_shares":24714},"source":{"system":"sec-edgar","filing":"0001415889-24-009270","document":"form4-03272024_110354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009270/form4-03272024_110354.xml","form_type":"4"}},{"id":1559832,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-27T23:57:03.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":80564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":80564,"derivative":{"exercise_price":17.84,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":80564},"source":{"system":"sec-edgar","filing":"0001415889-24-009270","document":"form4-03272024_110354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009270/form4-03272024_110354.xml","form_type":"4"}},{"id":1559831,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-27T23:57:03.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":5434,"price":17.9,"value":97268.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":26183,"source":{"system":"sec-edgar","filing":"0001415889-24-009270","document":"form4-03272024_110354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009270/form4-03272024_110354.xml","form_type":"4"}},{"id":1559830,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-27T23:57:03.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":10550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at 50% of target"}],"balance_after":31617,"source":{"system":"sec-edgar","filing":"0001415889-24-009270","document":"form4-03272024_110354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009270/form4-03272024_110354.xml","form_type":"4"}},{"id":1616817,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-02-27T23:13:45.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":false,"shares":1353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":1353,"derivative":{"underlying":"Common Stock","underlying_shares":1353},"source":{"system":"sec-edgar","filing":"0001415889-24-005577","document":"form4-02272024_110237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005577/form4-02272024_110237.xml","form_type":"4"}},{"id":1616816,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T23:13:45.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":772,"price":24.67,"value":19045.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":21067,"source":{"system":"sec-edgar","filing":"0001415889-24-005577","document":"form4-02272024_110237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005577/form4-02272024_110237.xml","form_type":"4"}},{"id":1616815,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-27T23:13:45.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":true,"shares":1353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":21839,"source":{"system":"sec-edgar","filing":"0001415889-24-005577","document":"form4-02272024_110237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005577/form4-02272024_110237.xml","form_type":"4"}},{"id":1733265,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T23:00:21.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":4956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":19826,"derivative":{"underlying":"Common Stock","underlying_shares":4956},"source":{"system":"sec-edgar","filing":"0001209191-23-056357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056357/doc4.xml","form_type":"4"}},{"id":1733264,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T23:00:21.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":4956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":19826,"derivative":{"underlying":"Common Stock","underlying_shares":4956},"source":{"system":"sec-edgar","filing":"0001209191-23-056357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056357/doc4.xml","form_type":"4"}},{"id":1733263,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:21.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":5108,"price":22.64,"value":115645.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.5753 to $22.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":20486,"source":{"system":"sec-edgar","filing":"0001209191-23-056357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056357/doc4.xml","form_type":"4"}},{"id":1733262,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:21.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":4956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":25594,"source":{"system":"sec-edgar","filing":"0001209191-23-056357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056357/doc4.xml","form_type":"4"}},{"id":1733261,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:21.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":4956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":20638,"source":{"system":"sec-edgar","filing":"0001209191-23-056357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056357/doc4.xml","form_type":"4"}},{"id":1798961,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-23T23:31:23.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":28.997,"value":289970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.75 to $29.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,593 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 15, 2023."}],"balance_after":15682,"source":{"system":"sec-edgar","filing":"0001209191-23-047125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123047125/doc4.xml","form_type":"4"}},{"id":1859409,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-06-13T00:48:18.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":false,"shares":1893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024."}],"balance_after":1893,"derivative":{"underlying":"Common Stock","underlying_shares":1893},"source":{"system":"sec-edgar","filing":"0001209191-23-036529","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123036529/doc4.xml","form_type":"4"}},{"id":1859408,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-13T00:48:18.000Z","date":"2023-06-08","kind":"sale","planned":false,"acquired":false,"shares":974,"price":25.02,"value":24369.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":22824,"source":{"system":"sec-edgar","filing":"0001209191-23-036529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123036529/doc4.xml","form_type":"4"}},{"id":1859407,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-13T00:48:18.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":true,"shares":1893,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23798,"source":{"system":"sec-edgar","filing":"0001209191-23-036529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123036529/doc4.xml","form_type":"4"}},{"id":1885486,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T22:48:18.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":14869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":24782,"derivative":{"underlying":"Common Stock","underlying_shares":14869},"source":{"system":"sec-edgar","filing":"0001209191-23-031243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031243/doc4.xml","form_type":"4"}},{"id":1885485,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T22:48:18.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":14869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":24782,"derivative":{"underlying":"Common Stock","underlying_shares":14869},"source":{"system":"sec-edgar","filing":"0001209191-23-031243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031243/doc4.xml","form_type":"4"}},{"id":1885484,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T22:48:18.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":15310,"price":22.5,"value":344475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":21905,"source":{"system":"sec-edgar","filing":"0001209191-23-031243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031243/doc4.xml","form_type":"4"}},{"id":1885483,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T22:48:18.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":14869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":37215,"source":{"system":"sec-edgar","filing":"0001209191-23-031243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031243/doc4.xml","form_type":"4"}},{"id":1885482,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T22:48:18.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":14869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":22346,"source":{"system":"sec-edgar","filing":"0001209191-23-031243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031243/doc4.xml","form_type":"4"}},{"id":1906753,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-04T01:15:11.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":27259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":27259,"derivative":{"underlying":"Common Stock","underlying_shares":27259},"source":{"system":"sec-edgar","filing":"0001209191-23-027205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027205/doc4.xml","form_type":"4"}},{"id":1906752,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-04T01:15:11.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":89936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":89936,"derivative":{"exercise_price":21.75,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":89936},"source":{"system":"sec-edgar","filing":"0001209191-23-027205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027205/doc4.xml","form_type":"4"}},{"id":1923193,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-08T00:37:32.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":5275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":15826,"derivative":{"underlying":"Common Stock","underlying_shares":5275},"source":{"system":"sec-edgar","filing":"0001209191-23-023863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023863/doc4.xml","form_type":"4"}},{"id":1923192,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-08T00:37:32.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":1916,"price":18.16,"value":34794.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.16 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":7477,"source":{"system":"sec-edgar","filing":"0001209191-23-023863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023863/doc4.xml","form_type":"4"}},{"id":1923191,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-08T00:37:32.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":5275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":9393,"source":{"system":"sec-edgar","filing":"0001209191-23-023863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023863/doc4.xml","form_type":"4"}},{"id":1991075,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T02:00:34.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":1353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":2706,"derivative":{"underlying":"Common Stock","underlying_shares":1353},"source":{"system":"sec-edgar","filing":"0001209191-23-013470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013470/doc4.xml","form_type":"4"}},{"id":1991074,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:34.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":577,"price":18.78,"value":10836.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":4118,"source":{"system":"sec-edgar","filing":"0001209191-23-013470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013470/doc4.xml","form_type":"4"}},{"id":1991073,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:34.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":1353,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":4695,"source":{"system":"sec-edgar","filing":"0001209191-23-013470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013470/doc4.xml","form_type":"4"}},{"id":2236576,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-11T00:51:46.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":1893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in three equal annual installments on each of June 8, 2022, June 8, 2023 and June 8, 2024."}],"balance_after":3786,"derivative":{"underlying":"Common Stock","underlying_shares":1893},"source":{"system":"sec-edgar","filing":"0001209191-22-036176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122036176/doc4.xml","form_type":"4"}},{"id":2236575,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-11T00:51:46.000Z","date":"2022-06-09","kind":"sale","acquired":false,"shares":653,"price":17.9095,"value":11694.9035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.91 to $18.449, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":3342,"source":{"system":"sec-edgar","filing":"0001209191-22-036176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122036176/doc4.xml","form_type":"4"}},{"id":2236574,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-11T00:51:46.000Z","date":"2022-06-08","kind":"exercise","acquired":true,"shares":1893,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3995,"source":{"system":"sec-edgar","filing":"0001209191-22-036176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122036176/doc4.xml","form_type":"4"}},{"id":2301761,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:49:46.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":21101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":21101,"derivative":{"underlying":"Common Stock","underlying_shares":21101},"source":{"system":"sec-edgar","filing":"0001209191-22-023741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023741/doc4.xml","form_type":"4"}},{"id":2301760,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-07T22:49:46.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":72414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":72414,"derivative":{"exercise_price":25.75,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":72414},"source":{"system":"sec-edgar","filing":"0001209191-22-023741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023741/doc4.xml","form_type":"4"}},{"id":2372880,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:43:53.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":1352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":4059,"derivative":{"underlying":"Common Stock","underlying_shares":1352},"source":{"system":"sec-edgar","filing":"0001209191-22-013281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013281/doc4.xml","form_type":"4"}},{"id":2372879,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:43:53.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":553,"price":23.8,"value":13161.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":2102,"source":{"system":"sec-edgar","filing":"0001209191-22-013281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013281/doc4.xml","form_type":"4"}},{"id":2372878,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":25550,"kind":"person","name":"Schneyer Mark C.","position":1,"cik":"0001899977","reported_name":"Schneyer Mark C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-25T22:43:53.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":1352,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2655,"source":{"system":"sec-edgar","filing":"0001209191-22-013281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013281/doc4.xml","form_type":"4"}}]}